Our Mission
The mission of OmegaBrite is to develop natural products of the highest quality that promote health and well being based on scientific evidence. We are proud of the overwhelming positive response we have received for our flagship product OmegaBrite 100% Natural Advanced Omega-3 Formula.
The goal in creating OmegaBrite was simply to create the best Omega-3 supplement possible with a formulation based on science. That meant doing things that had never been done before, such as creating a super high 90% concentrate of pure Omega-3, creating the first high EPA Omega-3 with 70% pure EPA and creating the first pharmaceutical grade Omega-3 supplement.
We were told what we wanted to create was impractical, too expensive to make, too difficult to distill to such a high purity. But we stuck to our goal of creating the best Omega-3 possible and brought to the world OmegaBrite, high concentrate, high EPA Omega-3 from fish oil with no after taste.
Award winning OmegaBrite 90% concentrated pure Omega-3 is easy to swallow in our tiny gelcaps. OmegaBrite is 70% pure EPA Omega-3 for maximum health benefits. The Omega-3 EPA is found in fish oil distilled through the best distillation with no exposure to oxygen for the purest Omega-3 your family can trust. OmegaBrite supplies your body with High Omega-3 EPA. EPA is the body's natural anti-inflammatory molecule. The high EPA in OmegaBrite gives real results in how you feel. We are excited that our OmegaBrite Kidz liquid is so popular giving children the tremendous benefits of Omega-3 with a flavor they like.
Awards
And we are very proud that OmegaBrite just received the Nutrition Business Journal Product Merit Award for creating the category of high concentrate Omega-3 supplements, bringing to the public the first high EPA Omega-3 supplement, educating the public on the health benefits of EPA and Omega-3 and raising the standards in the industry for purity and quality. In reviews of pharmaceutical grade fish oil by Consumer labs and top universities, OmegaBrite High EPA Pharmaceutical Grade Omega-3 concentrate from fish oil tops the list as we created the category and are the gold standard for purity, concentration and scientific efficacy."
Our commitment to purity, safety and efficacy is the foundation of everything we do. We set the standard in Omega-3's to bring you the very best from science and nature.
The Company
Omega Natural Science is the leading provider of Omega-3 and nutritional supplements based on the scientific evidence of efficacy of Omega-3 fatty acids for improving cardiac, emotional well-being, joint comfort and overall health. OmegaBrite was first formulated by Dr. Locke in 1998 while on the faculty at Harvard Medical School and brought to the public in 1999.
Omega Natural Science is located in Waltham, Massachusetts, we use the most advanced manufacturing processes, in GMP compliant facilities, to provide the highest purity Omega-3 products on the market. Omega Natural Science is committed to helping its customers lead healthier lives.
The mission of OmegaBrite is to develop natural products of the highest quality that promote health and well being based on scientific evidence. We are proud of the overwhelming positive response we have received for our flagship product OmegaBrite 100% Natural Advanced Omega-3 Formula.
The goal in creating OmegaBrite was simply to create the best Omega-3 supplement possible with a formulation based on science. That meant doing things that had never been done before, such as creating a super high 90% concentrate of pure Omega-3, creating the first high EPA Omega-3 with 70% pure EPA and creating the first pharmaceutical grade Omega-3 supplement.
We were told what we wanted to create was impractical, too expensive to make, too difficult to distill to such a high purity. But we stuck to our goal of creating the best Omega-3 possible and brought to the world OmegaBrite, high concentrate, high EPA Omega-3 from fish oil with no after taste.
Award winning OmegaBrite 90% concentrated pure Omega-3 is easy to swallow in our tiny gelcaps. OmegaBrite is 70% pure EPA Omega-3 for maximum health benefits. The Omega-3 EPA is found in fish oil distilled through the best distillation with no exposure to oxygen for the purest Omega-3 your family can trust. OmegaBrite supplies your body with High Omega-3 EPA. EPA is the body's natural anti-inflammatory molecule. The high EPA in OmegaBrite gives real results in how you feel. We are excited that our OmegaBrite Kidz liquid is so popular giving children the tremendous benefits of Omega-3 with a flavor they like.
Awards
And we are very proud that OmegaBrite just received the Nutrition Business Journal Product Merit Award for creating the category of high concentrate Omega-3 supplements, bringing to the public the first high EPA Omega-3 supplement, educating the public on the health benefits of EPA and Omega-3 and raising the standards in the industry for purity and quality. In reviews of pharmaceutical grade fish oil by Consumer labs and top universities, OmegaBrite High EPA Pharmaceutical Grade Omega-3 concentrate from fish oil tops the list as we created the category and are the gold standard for purity, concentration and scientific efficacy."
Our commitment to purity, safety and efficacy is the foundation of everything we do. We set the standard in Omega-3's to bring you the very best from science and nature.
The Company
Omega Natural Science is the leading provider of Omega-3 and nutritional supplements based on the scientific evidence of efficacy of Omega-3 fatty acids for improving cardiac, emotional well-being, joint comfort and overall health. OmegaBrite was first formulated by Dr. Locke in 1998 while on the faculty at Harvard Medical School for her patients and the public. Dr. Locke recognized the scientific evidence for Omega-3's and health. With no true Omega-3 available for her patients or the public at the time, Dr. Locke set out to create the first high purity,high concentrate Omega-3 supplement and formulated OmegaBrite, a 90% Omega-3, 70% EPA supplement designed for improving mood, cardiac health, and joint comfort. Dr. Locke founded Omega Natural Science to bring the first true high purity and high concentrate Omega-3 supplement to the public. Now in 99 countries with over half of all referrals from doctors and health care providers, OmegaBrite sets the gold standard for purity, quality and commitment to evidence based natural supplements.
Omega Natural Science is located in Waltham, Massachusetts, we use the most advanced manufacturing processes, in GMP compliant facilities, to provide the highest purity Omega-3 products on the market. Omega Natural Science is committed to helping its customers lead healthier lives.
About Dr. Locke
Dr. Locke is the founder of the Center for Creating Health in Southern California. The Center for Creating Health brings an integrative evidence based focus to improving people's lives. At the center Dr. Locke sees patients and continues to work on the research and development of new natural products to better help her patients and the general public live better, longer more zestful lives.
Dr. Locke is a leader in educating both the medical community and the public of the health benefits of Omega-3 fatty acids. Deeply Committed to promoting awareness of the health benefits of Omega-3 fatty acids around the world, Dr. Locke has spearheaded the creation and launch of the first International Omega-3 Awareness Day for March 3 2010. Visit Omega3day.com to learn more. For more about Dr. Locke and her clinical practice visit CarolLockeMD.com
Dr. Locke's CV
| Name: | Carol A. Locke, M.D. President and Founder Omega Natural Science, Inc |
| Address: | Omega Natural Science, Inc. 1050 Winter Street – Suite 1000 Waltham, MA 02420 Phone: 781 652 0503 Fax: 781.652.0504 |
Educational Degrees
| 1979-82 | B.A. University of California at Berkeley Highest Honors in Anthropology, High Distinction in General Scholarship |
| 1982-86 | M.D. Harvard Medical School, Boston, MA |
Awards and Honors
| 1981 | Phi Beta Kappa, University of California at Berkeley |
| 1980 | Torch and Shield Scholarship |
| 1981 | Pyrtanean Honor Society for Outstanding Women Scholars |
| 1981 | Clara and Claribel Farno Scholarship |
| 1981 | Phoebe A. Hearst Scholarship |
| 1981 | Eugene Wilson Scholarship |
| 1982 | Highest Honors in Anthropology |
| 1982 | High Distinction in General Scholarship |
| 1983 | Summer Fellow, National Institute of Medicine |
| 1984 | Sacramento Medical Society Scholarship |
| 1989 | American Psychiatric Association Mead-Johnson Fellowship |
| 1990 | Mel Kayce Award, McLean Hospital |
| 2007 | Product of Merit Award for OmegaBrite, Nutrition Business Journal |
Fellowships and Postdoctoral Training
| 1979 | President’s Undergraduate Fellowship, U.C. Berkeley |
| 1983 | National Academy of Science Summer Fellowship |
| 1987-90 | Resident in Adult Psychiatry, McLean Hospital, Belmont, MA |
| 1989-90 | American Psychiatric Association Mead Johnson Fellowship |
| 1989-90 | Cognitive Behavioral Therapy Fellowship, McLean Hospital |
| 1989-90 | Chief Resident, Affective Disorders Program, McLean Hospital |
Licensure and Certification
| 1992-Present | California Medical License |
| 1988-1991 | New Hampshire Medical License |
| 1992-2005 | Massachusetts Medical License |
| 1987 | DEA Registration Federal and State |
| 1987 | Diplomate, National Board of Medical Examiners |
| 1992 | Diplomate, American Board of Psychiatry and Neurology |
Academic Appointments
| 1987-90 | Clinical Fellow, Harvard Medical School |
| 1990 | Chief Resident in Affective Disorders Program |
| 1990 | Fellow in Cognitive Behavioral Medicine |
| 1990-1998 | Instructor in Psychiatry, McLean Hospital |
| 1998-2004 | Associate Attending Psychiatrist, Harvard Medical School |
Hospital or Affiliated Institution Appointments
| 7/1987-6/90 | Resident in Adult Psychiatry, McLean Hospital. |
| 7/1989-6/90 | Medical Staff Psychiatrist, Westwood Lodge, Westwood, MA |
| 7/1988-6/91 | Medical Staff Psychiatrist, Hampstead Hospital, NH |
| 7/1988-6/90 | Medical Staff Psychiatrist, Norwood Hospital, Brookline, MA. |
| 7/1989-6/90 | Chief Resident, Affective Disorders Program, McLean Hospital |
| 7/1990-6/91 | Psychiatrist-in-Charge on South Belknap II, an inpatient psychiatric unit at McLean Hospital |
| 7/1990-6/98 | Assistant Attending Psychiatrist, McLean Hospital |
| 7/1998-6/04 | Associate Attending Psychiatrist, McLean Hospital |
Professional Societies:
| 1982- | Member, American Medical Association |
| 1987- | Member, Massachusetts Medical Society |
| 1987- | Member, American Psychiatric Association |
| 2000-2004 | Member, Massachusetts Psychiatric Society |
| 2001- | Women’s Leadership Board, Kennedy School of Government |
| 2005-2006 | Science Club for Girls, Board Member |
| 2006- | Women’s Presidents Organization |
| 2007- | American Oil Chemists’ Society |
| 2008- | American Medical Association |
Research Activities
| 1981 | Principal Investigator, Fiji Islands, University of California at Berkeley, Department of Anthropology. Investigation of factors in the meaning of health and choice of health care in a rural Fijian Village, as a Present’s Undergraduate Fellow. |
| 1983 | Principal Investigator of a study examining the cultural Influences on the bereavement process in three Boston Hispanic Communities, as a Summer Fellow, National Institute of Medicine. |
| 1989-90 | Co-Principal Investigator on study of factors related to suicide. |
| 1990 | Co-Principal Investigator on the role of Prozac-associated akathisia (motor restlessness) on suicidal behavior. |
| 1998- | Principal and Co-investigator on a series of clinical studies on the role of omega-3 fatty acids in mood disorders. |
Bibliography
Original Articles
- Rothschild AS, Locke CA. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry 1991;52:491-493.
- Rothschild AS, Locke CA: Reply to Letter to Editor. J Clin Psychiatry 1992;53:256-75.
- Stoll AL, Locke CA, Vuckovic A, Mayer PV. Lithium associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series. J Clin Psychiatry 1996;57:356-9.
- Stoll AL, Locke CA, Marangell LB, Severus WE. Omega-3 fatty acids and bipolar disorder: A review. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 1999 May-June;60(5-6)329-37.
- Locke CA, Stoll AL. Omega-3 fatty acids in major depression. World Rev Nutr Diet. 2001;89:173-85.
Abstracts
- Locke CA, Rothschild A, Stoll AL, Murray M, Goldstein E. Completed suicides in a psychiatric hospital: A controlled retrospective study. Abstracts of the First Annual Harvard Medical School Research Day, Boston, 1993.
Book Chapters
- Stoll AL, Locke CA. Omega-3 fatty acids in mood disorders: a review of neurobiological and clinical actions. In Natural Medicines in Psychiatry (Eds: D Mischoulon and J Rosenbaum). Wiley and Co. 2001.
